"ROLE OF ALLOGENEIC TRANSPLANTATION IN MULTIPLE MYELOMA IN THE ERA OF NEW DRUGS"
High-dose melphalan with autologous stem cell rescue has been regarded as the standard of care for patients with newly diagnosed myeloma up to the age of 65-70 years. The recent development of agents with potent anti-tumor activity such as thalidomide, lenalidomide and bortezomib has further improve...
| Published in: | Mediterranean Journal of Hematology and Infectious Diseases |
|---|---|
| Main Authors: | , , , |
| Format: | Article |
| Language: | English |
| Published: |
PAGEPress Publications
2010-06-01
|
| Subjects: | |
| Online Access: | http://www.mjhid.org/index.php/mjhid/article/view/176 |